Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Biao Qu, Rong Xing, Hong Wang, Xin Chen, Qin Ge, Daiyin Peng & Guangji Wang. (2017) Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury. Xenobiotica 47:4, pages 290-296.
Read now
Read now
Kazuo Tarao, Shinichi Ohkawa, Yohei Miyagi, Soichiro Morinaga, Kenji Ohshige, Naoto Yamamoto, Makoto Ueno, Satoshi Kobayashi, Ryo Kameda, Setsuo Tamai, Yoshiyasu Nakamura, Kaoru Miyakawa, Yoichi Kameda & Masahiko Okudaira. (2013) Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis. Scandinavian Journal of Gastroenterology 48:6, pages 729-735.
Read now
Read now
J.-H. Tu, D.-L. Hu, L.-L. Dai, Y. Sun, L. Fan, M. Zhang, Z.-R. Tan, Y. Chen, Z. Li & H.-H. Zhou. (2010) Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes. Xenobiotica 40:6, pages 393-399.
Read now
Read now
Yong-Song Guan, Qing He, Ming-Quan Wang & Ping Li. (2008) Nuclear factor kappa B and hepatitis viruses. Expert Opinion on Therapeutic Targets 12:3, pages 265-280.
Read now
Read now
Articles from other publishers (30)
Sukhbir Singh, Neelam Sharma, Saurabh Shukla, Tapan Behl, Sumeet Gupta, Md. Khalid Anwer, Celia Vargas-De-La-Cruz, Simona Gabriela Bungau & Cristina Brisc. (2023) Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics. Molecules 28:6, pages 2811.
Crossref
Crossref
Rhian Stavely, Lauren Sahakian, Rhiannon T. Filippone, Vanesa Stojanovska, Joel C. Bornstein, Samy Sakkal & Kulmira Nurgali. (2022) Oxidative Stress-Induced HMGB1 Translocation in Myenteric Neurons Contributes to Neuropathy in Colitis. Biomolecules 12:12, pages 1831.
Crossref
Crossref
Fahmida Rasha, Subhojit Paul, Tracey G. Simon & Yujin Hoshida. (2022) Hepatocellular Carcinoma Chemoprevention with Generic Agents. Seminars in Liver Disease 42:04, pages 501-513.
Crossref
Crossref
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Naomi Ideno, Tatsuji Komatsu, Takaaki Ikeda, Masataka Taguri & Shin Maeda. (2022) Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients. World Journal of Meta-Analysis 10:3, pages 186-194.
Crossref
Crossref
Alaa F. Bakr, Ping Shao & Mohamed A. Farag. (2022) Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review. Phytomedicine 99, pages 153999.
Crossref
Crossref
Yi Chen, Wenmin Zhang, Hui Bao, Wubing He & Lihong Chen. (2021) High Mobility Group Box 1 Contributes to the Acute Rejection of Liver Allografts by Activating Dendritic Cells. Frontiers in Immunology 12.
Crossref
Crossref
Xia Liao, Yang Bu & Qingan Jia. (2020) Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes & Diseases 7:3, pages 370-379.
Crossref
Crossref
Cory Szybala, Mollie Parker Szybala & Peter B. Bongiorno. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
1358
1367.e4
.
Bilon Khambu, Shengmin Yan, Nazmul Huda & Xiao-Ming Yin. (2019) Role of High-Mobility Group Box-1 in Liver Pathogenesis. International Journal of Molecular Sciences 20:21, pages 5314.
Crossref
Crossref
Sai Krishna Athuluri‐Divakar & Yujin Hoshida. (2018) Generic chemoprevention of hepatocellular carcinoma. Annals of the New York Academy of Sciences 1440:1, pages 23-35.
Crossref
Crossref
Ari Rouhiainen, Niko-Petteri Nykänen, Juha Kuja-Panula, Päivi Vanttola, Henri Huttunen & Heikki Rauvala. (2018) Inhibition of Homophilic Interactions and Ligand Binding of the Receptor for Advanced Glycation End Products by Heparin and Heparin-Related Carbohydrate Structures. Medicines 5:3, pages 79.
Crossref
Crossref
Celine Hernandez, Peter Huebener, Jean-Philippe Pradere, Daniel J. Antoine, Richard A. Friedman & Robert F. Schwabe. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. Journal of Clinical Investigation 128:6, pages 2436-2451.
Crossref
Crossref
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens & Yujin Hoshida. (2018) Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. Journal of Hepatology 68:3, pages 526-549.
Crossref
Crossref
Devesh Tewari, Andrei Mocan, Emil D. Parvanov, Archana N. Sah, Seyed M. Nabavi, Lukasz Huminiecki, Zheng Feei Ma, Yeong Yeh Lee, Jarosław O. Horbańczuk & Atanas G. Atanasov. (2017) Ethnopharmacological Approaches for Therapy of Jaundice: Part II. Highly Used Plant Species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae Families. Frontiers in Pharmacology 8.
Crossref
Crossref
Yifei Yang, Lingyun Yang, Yaodan Han, Zhenwei Wu, Pan Chen, Huibin Zhang & Jinpei Zhou. (2017) Protective effects of hepatocyte-specific glycyrrhetic derivatives against carbon tetrachloride-induced liver damage in mice. Bioorganic Chemistry 72, pages 42-50.
Crossref
Crossref
Robert Domitrović & Iva Potočnjak. (2015) A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives. Archives of Toxicology 90:1, pages 39-79.
Crossref
Crossref
Xuanbin Wang, Ning Wang, Fan Cheung, Lixing Lao, Charlie Li & Yibin Feng. (2015) Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms. Journal of Integrative Medicine 13:3, pages 142-164.
Crossref
Crossref
Kai Jie Chen, Wan Yi Chen, Xia Chen, Yi Ming Jia, Gui Qin Peng & Li Chen. (2013) Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study. European Journal of Drug Metabolism and Pharmacokinetics 39:1, pages 25-31.
Crossref
Crossref
Arthur Lau, Shuang Wang, Weihua Liu, Aaron Haig, Zhu-Xu Zhang & Anthony M. Jevnikar. (2014) Glycyrrhizic Acid Ameliorates HMGB1-Mediated Cell Death and Inflammation after Renal Ischemia Reperfusion Injury. American Journal of Nephrology 40:1, pages 84-95.
Crossref
Crossref
Xuanbin Wang, Yibin Feng, Ning Wang, Fan Cheung, Hor Yue Tan, Sen Zhong, Charlie Li & Seiichi Kobayashi. (2014) Chinese Medicines Induce Cell Death: The Molecular and Cellular Mechanisms for Cancer Therapy. BioMed Research International 2014, pages 1-14.
Crossref
Crossref
V. Carreño. (2014) Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy. Alimentary Pharmacology & Therapeutics 39:2, pages 148-162.
Crossref
Crossref
Melissa Palmer & Peter B. Bongiorno. 2013. Textbook of Natural Medicine. Textbook of Natural Medicine
1409
1418
.
M. P. Manns, H. Wedemeyer, A. Singer, N. Khomutjanskaja, H. P. Dienes, T. Roskams, R. Goldin, U. Hehnke & H. Inoue. (2012) Glycyrrhizin in patients who failed previous interferon alpha‐based therapies: biochemical and histological effects after 52 weeks. Journal of Viral Hepatitis 19:8, pages 537-546.
Crossref
Crossref
Anna Del Prete, Antonella Scalera, Maddalena Diana Iadevaia, Agnese Miranda, Claudio Zulli, Laura Gaeta, Concetta Tuccillo, Alessandro Federico & Carmelina Loguercio. (2012) Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-19.
Crossref
Crossref
Eric YarnellKathy Abascal. (2010) Herbal Medicine for Viral Hepatitis. Alternative and Complementary Therapies 16:3, pages 151-157.
Crossref
Crossref
Kazuo TARAO, Yasunari SAKAMOTO, Makoto UENO, Kaoru MIYAKAWA & Shinichi OKAWA. (2010) Juzentaihoto (TJ-48) may be An Important and Effective Anti-Inflammatory Agent for Intractable Cases of Patients with HCV-associated Chronic Liver Diseases. Kampo Medicine 61:1, pages 1-8.
Crossref
Crossref
Yibin Feng, Kwok-Fan Cheung, Ning Wang, Ping Liu, Tadashi Nagamatsu & Yao Tong. (2009) Chinese medicines as a resource for liver fibrosis treatment. Chinese Medicine 4:1.
Crossref
Crossref
Kenjiro Koga, Michiko Tomoyama, Kazuo Ohyanagi & Kanji Takada. (2008) Pharmacokinetics of glycyrrhizin in normal and albumin‐deficient rats. Biopharmaceutics & Drug Disposition 29:7, pages 373-381.
Crossref
Crossref
Kaoru Ishizaki, Tomomichi Iwaki, Shuji Kinoshita, Mamoru Koyama, Atsushi Fukunari, Hideki Tanaka, Makoto Tsurufuji, Kei Sakata, Yasuhiro Maeda, Teruaki Imada & Kenji Chiba. (2008) Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-α and macrophage inflammatory protein-2 production. European Journal of Pharmacology 578:1, pages 57-64.
Crossref
Crossref
Apurva A Modi, Elizabeth C Wright & Leonard B Seeff. (2006) Complementary and alternative Medicine (CAM) for the Treatment of Chronic Hepatitis B and C: A Review. Antiviral Therapy 12:3, pages 285-296.
Crossref
Crossref